FDA: Mela Sciences’s Melafind Skin Cancer Biopsy Replacement May Cause “More Harm Than Good”

Mass Device -- The Food & Drug Administration raises concerns over Mela Sciences Inc.'s melanoma-detection device two days ahead of its pre-market approval vote by an agency panel.